What is alpha thalassemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Alpha Thalassemia

Alpha thalassemia is an autosomal recessive inherited blood disorder caused by decreased or absent synthesis of alpha-globin chains due to mutations affecting one to all four alpha-globin genes located on chromosome 16, resulting in a clinical spectrum ranging from asymptomatic carrier states to lethal hemolytic anemia. 1

Genetic Basis and Pathophysiology

  • The alpha-globin gene cluster maps to the short arm of chromosome 16, with each chromosome normally containing two alpha-globin genes (α2 and α1), giving a total of four functional alpha-globin genes in diploid cells 2
  • Disease severity directly correlates with the number of affected genes: deletion or inactivation of 1,2,3, or all 4 alpha-globin genes produces progressively more severe phenotypes 1
  • Most cases result from gene deletions (ranging from 3 to over 100 kb) caused by unequal crossing-over during meiosis, though point mutations affecting mRNA processing or producing unstable polypeptide chains also occur 2
  • The fundamental pathophysiology involves imbalanced globin chain production, leading to ineffective erythropoiesis, decreased red blood cell survival, and chronic hemolytic anemia 3

Clinical Phenotypes by Genotype

Silent Carrier (One Gene Deletion: -α/αα)

  • Clinically asymptomatic with normal or near-normal hematological parameters 1
  • No treatment required 1

Alpha Thalassemia Trait (Two Gene Deletions: --/αα or -α/-α)

  • Microcytic hypochromic anemia that does NOT respond to iron supplementation 4
  • Mean corpuscular volume (MCV) typically <80 fL with reduced mean corpuscular hemoglobin (MCH) 4
  • Generally asymptomatic with only limited alterations in hematological parameters 2
  • No treatment required 1

Hemoglobin H Disease (Three Gene Deletions: --/-α)

  • Moderate to severe hemolytic anemia with variable degree of ineffective erythropoiesis and splenomegaly 5
  • Produces hemoglobin composed entirely of beta chains (HbH), detectable at levels of 0.8-40% 1
  • Critical distinction: Nondeletional mutations (e.g., Hb H Constant Spring) cause more severe disease than deletional mutations, with approximately one-third requiring regular transfusions versus uncommon transfusions for deletional types 5
  • May require intermittent transfusion therapy, especially during intercurrent illness 1

Hemoglobin Bart's Hydrops Fetalis (Four Gene Deletions: --/--)

  • Lethal form with complete absence of alpha-globin synthesis 1
  • Distinguished by presence of Hb Bart's and total absence of fetal hemoglobin (HbF) 1
  • Most common cause of nonimmune hydrops fetalis in Southeast Asian populations, accounting for 28-55% of cases in these regions 4
  • Fetus suffers severe intrauterine hypoxia from early gestational age because Bart's hemoglobin is an ineffective oxygen carrier, typically presenting with hydrops in late second or early third trimester 4
  • Most pregnancies are terminated due to increased risk of maternal and fetal morbidity 1

Geographic Distribution and Epidemiology

  • Probably the most common monogenic gene disorder worldwide 1
  • Highest frequency in Mediterranean countries, Southeast Asia, Africa, the Middle East, and the Indian subcontinent—regions with historical endemic malaria exposure 1
  • Incidence has increased in North-European countries and North America due to demographic changes 1

Diagnostic Approach

  • All affected individuals demonstrate anemia (low hemoglobin), reduced MCH, reduced MCV, and normal or slightly reduced HbA2 levels 1
  • Parents can be screened by evaluating mean cell volume: carriers will have MCV <80 fL 4
  • Molecular analysis is usually required to confirm haematological observations, especially in silent carriers and trait forms 1
  • Diagnosis of affected fetuses can be made by detection of common DNA deletions or point mutations, or by fetal blood sampling to evaluate for abnormal Bart's hemoglobin 4

Critical Clinical Pitfalls

  • Do not prescribe iron supplementation to patients with confirmed alpha thalassemia trait—it provides no benefit and may contribute to unnecessary iron accumulation 6
  • Always check serum ferritin to rule out concurrent iron deficiency before attributing microcytic anemia solely to thalassemia trait 6
  • Consider ethnicity in the diagnostic approach, as alpha thalassemia is significantly more common in specific populations 6
  • In pregnant women of appropriate ancestry with persistent mild anemia unresponsive to prenatal iron supplementation, further evaluation with MCV, RDW, and hemoglobin electrophoresis is indicated 6

References

Research

Alpha-thalassaemia.

Orphanet journal of rare diseases, 2010

Research

Alpha-thalassaemia.

Bailliere's clinical haematology, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Beta Thalassemia Trait Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.